Tower Hamlets Protests £330m NHS Palantir Contract in Royal London Hospital 2026

Key Points

• Local and International Protests: Campaigners gathered outside the Royal London Hospital in Tower Hamlets as part of a synchronized global “People vs Palantir” day of action spanning Europe, the Americas, and Australia.
• Contract Details: Palantir secured a £330 million contract in November 2023 to run the NHS Federated Data Platform (FDP) following initial involvement that began in 2020.
• Break Clause Targeted: Demonstrators are pressing the UK government to trigger a contractual break clause scheduled for February 2027 to end the agreement early.
• Ethical and Data Privacy Concerns: Activists and healthcare professionals voiced fears regarding patient data privacy, citing Palantir’s supply of technology to military and surveillance bodies, including the Israel Defence Forces (IDF), the US Immigration and Customs Enforcement (ICE), and western militaries.
• Political Opposition: Local Green Party representative Councillor Ottilie Daisy Swinyard called for the NHS digital framework to be updated using providers that reflect public health service values.

Tower Hamlets (East London Times) October 6, 2026 – Demonstrators assembled outside the Royal London Hospital last Thursday to call on NHS leadership and the UK government to immediately sever ties with American software company Palantir. The action saw campaigners chant “Andy Burnham hear us now, get Palantir out now” as they demanded the cancellation of the healthcare service’s £330 million deal. Organisers are urging ministers to utilise an upcoming contractual break clause due in February 2027 to end Palantir’s management of England’s health data infrastructure.

Why Are Tower Hamlets Residents Protesting Against Palantir in the NHS?

The protest in East London formed part of a coordinated international movement known as “People vs Palantir”. Activists across North America, South America, Europe, and Australia staged simultaneous demonstrations targeting the technology vendor’s global public sector footprint.

In Tower Hamlets, the demonstration brought together a wide coalition of civil society organisations, campaign groups, and healthcare workers. Participating bodies included the Palestine Solidarity Campaign, Health Workers for a Free Palestine, Amnesty International, Medact, Keep Our NHS Public, Just Treatment, and Doctors of the UK.

Speaking on behalf of the local opposition, Tower Hamlets Green Party Councillor Ottilie Daisy Swinyard expressed fundamental objections to the American firm’s involvement in state healthcare provision. Swinyard stated that Palantir does not care about the NHS and certainly does not care about patients. While acknowledging that the digital systems within the NHS require modernising, Swinyard emphasised a preference for alternative tech partners whose core values align with the ethos of the public health service.

What Is the £330m NHS Federated Data Platform Contract?

Palantir’s official relationship with the National Health Service began in 2020 during the initial emergency digital response to the COVID-19 pandemic. Following a subsequent procurement process, the company was awarded a £330 million contract in November 2023 to design and operate the NHS Federated Data Platform (FDP).

The FDP system was created to integrate disparate data software across individual hospital trusts and regional integrated care systems throughout England. The stated objective of the platform is to assist administrative staff and clinicians with resource planning, operational management, and the reduction of patient waiting lists by connecting nationwide population data. However, the scope of this platform grants the enterprise broad technical access to aggregated patient information across the national healthcare ecosystem.

Why Is Palantir Facing Global Criticism Over Its Defence and Surveillance Ties?

Opponents of the NHS deal point to Palantir’s wider commercial activities in military intelligence, state surveillance, and law enforcement as primary reasons for concern. Campaigners argue that an enterprise heavily involved in defence contracting is unsuitable to manage sensitive civilian medical records.

Specific criticisms focus on Palantir’s provision of analytical software to the Israel Defence Forces (IDF), the United States Department of Defense, the British Armed Forces, and the US Immigration and Customs Enforcement (ICE) agency.

Highlighting these connections, a member of East London Health Workers for a Free Palestine voiced significant concern over population data security. The representative noted extreme anxiety regarding Palantir’s access to NHS population datasets, referencing public statements made by company founder Peter Thiel and highlighting the software provider’s involvement with ICE in North America as a precedent for how data systems can be used by governmental authorities.

What Is the Background of Palantir’s NHS Expansion?

The integration of Palantir into the United Kingdom’s public health system represents a major shift in how national patient data is stored, shared, and analysed. When the NHS initially engaged the firm in March 2020, software was deployed under emergency procurement rules to track hospital bed availability, personal protective equipment (PPE) inventory, and ventilator distribution during the pandemic crisis.

Following the initial emergency phase, the Department of Health and Social Care sought to establish a permanent, unified digital architecture across England’s health network. This led to the launch of the Federated Data Platform tender. Despite legal challenges, data privacy concerns raised by civil liberties organisations, and opposition from professional medical bodies regarding patient consent frameworks, Palantir was formally awarded the £330 million contract in late 2023.

The five-year deal includes specific break options built into the contractual terms. The most significant milestone is a designated break clause scheduled for February 2027, which would allow the Secretary of State for Health and Social Care to terminate the contract prior to its full term without incurring standard financial penalties. This specific mechanism has now become the focal point for pressure groups and political campaigners nationwide.

What Are the Future Predictions for NHS Patients and Data Privacy Policy?

This growing opposition campaign and the upcoming 2027 break clause could have far-reaching consequences for NHS governance, public trust, and technology procurement policy.

• Impact on Patient Trust and Consent Opt-Outs: Continued publicity around Palantir’s military contracts and corporate leadership risks eroding public trust in NHS data security. This could lead to a rise in patients choosing to opt out of national data-sharing schemes, potentially undermining the statistical accuracy and medical usefulness of national health databases.
• Political Pressure on Government Procurement: As the February 2027 decision point approaches, ministers will face mounting pressure from backbench MPs, health unions, and international human rights organisations to exercise the break clause. Decoupling from Palantir would require the government to re-tender the FDP or bring data management back under direct public operation, potentially causing logistical delays in modernising hospital administration.
• Precedent for Commercial Tech Vendors in Healthcare: The outcome of this dispute will send a clear message to international technology companies seeking UK public sector contracts. If public resistance successfully forces the termination of the contract, future healthcare procurement standards will likely place strict ethical, human rights, and data-sovereignty requirements alongside standard technical capability.